Detalhe da pesquisa
1.
Exposure-response for biomarkers of anticoagulant effects by the oral direct thrombin inhibitor AZD0837 in patients with atrial fibrillation.
Br J Clin Pharmacol
; 80(6): 1362-73, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26174611
2.
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists.
Eur Heart J
; 30(23): 2897-907, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19690349
3.
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.
Circulation
; 127(18): 1916-26, 2013 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-23545139
4.
Atrial fibrillatory rate and risk of stroke in atrial fibrillation.
Europace
; 11(5): 582-6, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19287016
5.
Interatrial conduction can be accurately determined using standard 12-lead electrocardiography: validation of P-wave morphology using electroanatomic mapping in man.
Heart Rhythm
; 5(3): 413-8, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18313600
6.
Fibrillatory rate response to candesartan in persistent atrial fibrillation.
Europace
; 10(10): 1138-44, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18664477
7.
Permanent atrial fibrillation in patients without structural heart disease is not associated with signs of infection by Chlamydia pneumoniae and Helicobacter pylori.
Acta Cardiol
; 63(4): 479-84, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18795586
8.
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
Circulation
; 123(10): 1144-50, 2011 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21321155
9.
2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
Circulation
; 123(10): e269-367, 2011 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21382897
10.
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Circulation
; 123(1): 104-23, 2011 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-21173346
11.
Direct thrombin inhibition and stroke prevention in elderly patients with atrial fibrillation: experience from the SPORTIF III and V Trials.
Stroke
; 38(11): 2965-71, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17885258
12.
Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
Am Heart J
; 153(6): 1006-12, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17540203
13.
Prolonged P wave duration in adults with secundum atrial septal defect: a marker of delayed conduction rather than increased atrial size?
Europace
; 9 Suppl 6: vi105-8, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17959685
14.
Low-energy ultrasound exposure of the streptokinase molecule may enhance but also attenuate its fibrinolytic properties.
Thromb Res
; 117(6): 713-20, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-15993473
15.
Direct action on the molecule is one of several mechanisms by which ultrasound enhances the fibrinolytic effects of reteplase.
Blood Coagul Fibrinolysis
; 17(2): 105-12, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16479192
16.
Prediction of sinus rhythm maintenance following DC-cardioversion of persistent atrial fibrillation - the role of atrial cycle length.
BMC Cardiovasc Disord
; 6: 11, 2006 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-16533393
17.
Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial.
Lancet
; 362(9397): 1691-8, 2003 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-14643116
18.
Time-frequency analysis of the surface electrocardiogram for monitoring antiarrhythmic drug effects in atrial fibrillation.
Am J Cardiol
; 95(4): 526-8, 2005 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15695146
19.
Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial.
JAMA
; 293(6): 690-8, 2005 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-15701910
20.
[Atrial fibrillation frequency a possible prognostic support in atrial fibrillation. FAF analysis gives hope for better therapeutic choice]. / Förmakens fibrilleringsfrekvens möjligt prognosstöd vid förmaksflimmer. FAF-analys ger hopp om bättre terapival.
Lakartidningen
; 107(32-33): 1839-43, 2010.
Artigo
em Sueco
| MEDLINE | ID: mdl-20873329